Opportunities for pharmacists to ease the burden of diabetes self-management continues to expand with advancements in technology. PTCE’s 2026 Diabetes Day of Education is the premier event for insights into best practices for the integration of continuous glucose monitoring (CGM) and emerging ketone monitoring technologies for people living with diabetes. Panel discussions and interactive sessions throughout the day will promote comprehensive care strategies, interpretation of CGM data, and counseling points for pharmacists to help people living with diabetes achieve better glycemic control.

Pharmacists are crucial members of the cardiology care team, given their expertise in managing the complex, multidrug regimens often required for patients with heart conditions. PTCE's 2026 Cardiology Day of Education will detail the latest advancements in cardiovascular care, exploring pathophysiology of rare and common cardiovascular conditions, updates to treatment guidelines, and emerging therapies. This full-day program of expert-led sessions offers pharmacists the opportunity to hone their skills in optimizing treatment, identifying cardiovascular risk factors, and improving patient outcomes.

Pharmacists are essential in helping patients overcome the challenges of central nervous system disorders, from managing complex drug regimens to navigating access to specialty medications. Join experienced faculty for PTCE’s 2026 Neurology Day of Education to explore the shared neurobiological mechanisms, updated treatment guidelines, and the latest therapeutic advancements across neurological conditions. Sessions throughout the day will equip pharmacists with practical strategies for improving medication adherence and ensuring patient-centered care.

Type 2 inflammation is the main driver in several chronic allergic and inflammatory conditions. Pharmacists are crucial in navigating the use of and access to biologic therapies for the treatment of type 2-mediated conditions. Experience a full day of expert insight into biologic therapy utilization at PTCE’s 2026 Immunology Specialty Day of Education. Across the full agenda, pharmacists will gain practice skills needed to optimize treatment, support patient adherence, and reduce the burden of type 2-mediated conditions.

Pharmacists play a vital role in supporting and optimizing care for people with mental health conditions, guiding them through complex, multi-step treatment plans. PTCE’s 2026 Psychiatry Day of Education supports pharmacists involved in managing therapies for patients with challenging, interconnected psychiatric disorders that involve psychosis and mood disorders. Expert-led sessions will highlight strategies to facilitate timely interventions and address issues of treatment nonadherence and adverse effect management.

Pharmacists are key members of the oncology care team involved in ensuring patients with breast cancer understand the intricate dosing, sequencing, and adverse effect profiles of specialized regimens. The 2026 Breast Cancer Day of Education provides oncology pharmacists with evidence-based updates on the use of targeted therapies including CDK4/6 inhibitors, PARP inhibitors, and HER2-targeted agents. Join PTCE for a full day of expert-led, case-based discussions designed to support understanding of mutational testing, managing challenging adverse effects, and driving patient adherence in both early-stage and metastatic disease.

The management of non-Hodgkin lymphoma (NHL) is complex, and oncology pharmacists play a critical role in mastering the complex integration and toxicity of novel agents. Join leading experts in hematologic cancers for PTCE's 2026 Lymphoma Day of Education to review the pathophysiology of NHL subtypes, including aggressive diffuse large B-cell lymphoma and relapsing follicular lymphoma, and pharmacology of novel agents in both frontline and relapsed settings. Register early for these expert-led sessions that will examine clinical and operational strategies for the integration of CAR T-cell therapy and bispecific antibodies in NHL treatment.

Lung cancer remains a global health challenge, and the treatment paradigm has been marked by a shift towards the adoption of precision medicine and immunotherapy. PTCE's 2026 Lung Cancer Day of Education will prepare oncology pharmacists to be leaders in facilitating biomarker testing and optimizing care across major subtypes. Save the date for a full-day of in-depth discussions covering resistance mechanisms, strategies to manage unique adverse effects, and optimal adherence to targeted oral therapies and immunotherapy regimens.

Effective multiple myeloma (MM) management relies on pharmacist expertise to navigate the intricate dosing and administration of therapies while providing critical supportive care. Experience a full day of insight with PTCE's 2026 Multiple Myeloma Day of Education, which will explore the strategic integration and sequencing of novel agents, including CAR T-cell therapy, bispecific antibodies, and traditional IMiDs and PIs in MM. Be a part of promoting best practices for mitigating adverse effects and ensuring proper REMS compliance for oral agents.

Pharmacists are key public health advocates, and they are uniquely positioned to counsel patients on prevention and combat the spread of infectious diseases. Each session presented at PTCE’s 2026 Infectious Diseases Day of Education will provide updates on chronic diseases and acute infections, including immunogenicity data. Essential counseling strategies to effectively educate patients and address vaccine hesitancy will be emphasized through case-based examples.

The specialty drug market continues to expand, positioning pharmacists as resources to navigate nuances of limited distribution networks, complex handling requirements, and personalized patient care. Specialty pharmacists can elevate their practice with PTCE and Asembia’s 2026 Specialty Pharmacy Day of Education to address the critical challenges of managing high-cost therapies for complex and rare diseases. Each session will provide key insights into access, adherence, and the intricate administration of specialized treatments across multiple disease states.